Studies have reported that entinostat may reverse cisplatin resistance via the Src‐Mcl‐1‐MDR1 pathway in ESCC cells, which also illustrates the significance of MDR1 in the cisplatin resistance of ESCC cells.136. This evidence concerns the gene ABCB1 and esophageal squamous cell carcinoma.